Effect of autologous hematopoietic stem cell transplantation on magnetic resonance imaging (MRI) lesion burden in patients with multiple sclerosis (MS).

被引：0
|
作者：
Burt, RK
Cohen, BA
Lobeck, LL
Karlin, K
Russell, E
Spero, K
Davis, F
Stefoski, D
Oyama, Y
Traynor, AE
Burns, W
机构：
[1] Northwestern Univ, Med Ctr, Chicago, IL 60611 USA
[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[3] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1812
引用
收藏
页码：421A / 421A
页数：1
相关论文
共 50 条
  • [1] Clinical outcomes of lymphoablative autologous hematopoietic stem cell transplantation (AHSCT) in multiple sclerosis (MS) patients
    Fedorenko, D.
    Nikolaev, I.
    Kanshina, D.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 210 - 210
  • [2] Selection of Patients With Multiple Sclerosis to Undergo Autologous Hematopoietic Stem Cell Transplantation
    Racke, Michael K.
    Imitola, Jaime
    [J]. JAMA NEUROLOGY, 2017, 74 (04) : 392 - 394
  • [3] Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis
    Ross, Lindsay A.
    Stropp, Lisa M.
    Cohen, Jeffrey A.
    [J]. NEUROLOGIC CLINICS, 2024, 42 (01) : 165 - 184
  • [4] Autologous hematopoietic stem cell transplantation: a cure for multiple sclerosis?
    Libbey, Jane E.
    Tsunoda, Ikuo
    Fujinami, Robert S.
    [J]. FUTURE NEUROLOGY, 2006, 1 (04) : 403 - 408
  • [5] Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple Sclerosis
    Rush, Carolina A.
    Atkins, Harold L.
    Freedman, Mark S.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2019, 9 (03):
  • [6] Safety of autologous hematopoietic stem cell transplantation in multiple sclerosis patients (aHSCT-in-MS): the Zurich experience
    Jelcic, I.
    Mueller, A. M.
    Stathopoulos, P.
    Wolfensberger, N.
    Thesenvitz, A.
    Ritter, K.
    Lutterotti, A.
    Schanz, U.
    Martin, R.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 380 - 380
  • [7] Autologous hematopoietic stem-cell transplantation (AHSCT)+/- consolidation therapy in multiple sclerosis (MS)
    Shevchenko, Y. L.
    Novik, A. A.
    Kuznetsov, A. N.
    Melnichenko, V. Y.
    Fedorenko, D. A.
    Ionova, T. I.
    Kartashov, A. V.
    Kurbatova, K. A.
    Gorodokin, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 30 - 30
  • [8] Quality of Life in Patients with Multiple Sclerosis after Autologous Hematopoietic Stem Cell Transplantation
    Carlos Olivares-Gazca, Juan
    Murrieta-Alvarez, Ivan
    Mauricio Olivares-Gazca, Jesus
    Itzayana Garcia-Navarrete, Yarely
    Cantero-Fortiz, Yahveth
    Leon-Pena, Andres A.
    Ruiz-Delgado, Guillermo J.
    Ruiz-Arguelles, Guillermo J.
    [J]. BLOOD, 2019, 134
  • [9] Quality of Life in Patients with Multiple Sclerosis after Autologous Hematopoietic Stem Cell Transplantation
    Carlos Olivares-Gazca, Juan
    Murrieta-Alvarez, Ivan
    Mauricio Olivares-Gazca, Jesus
    Cantero-Fortiz, Yahveth
    Itzayana Garcia-Navarrete, Yarely
    Leon-Pena, Andres
    Fernanda Sanchez-Valledor, Luisa
    Cruz-Mora, Antonio
    Ruiz-Delgado, Guillermo J.
    Jose Ruiz-Arguelles, Guillermo
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S360 - S360
  • [10] Quality of life (QoL) assessment in multiple sclerosis (MS) patients undergoing autologous hematopoietic stem cell transplantation (AHSCT)
    Fedorenko, D.
    Nikolaev, I.
    Kanshina, D.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 913 - 913
12345